ACADIA Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACAD and other ETFs, options, and stocks.

About ACAD

ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. 

CEO
Catherine Owen Adams
CEOCatherine Owen Adams
Employees
798
Employees798
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1993
Founded1993
Employees
798
Employees798

ACAD Key Statistics

Market cap
3.76B
Market cap3.76B
Price-Earnings ratio
9.54
Price-Earnings ratio9.54
Dividend yield
Dividend yield
Average volume
1.22M
Average volume1.22M
High today
$22.35
High today$22.35
Low today
$21.65
Low today$21.65
Open price
$22.31
Open price$22.31
Volume
1.38M
Volume1.38M
52 Week high
$28.35
52 Week high$28.35
52 Week low
$14.45
52 Week low$14.45

Stock Snapshot

With a market cap of 3.76B, ACADIA Pharmaceuticals(ACAD) trades at $21.95. The stock has a price-to-earnings ratio of 9.54.

During the trading session on 2026-05-02, ACADIA Pharmaceuticals(ACAD) shares reached a daily high of $22.35 and a low of $21.65. At a current price of $21.95, the stock is +1.4% higher than the low and still -1.8% under the high.

Trading activity shows a volume of 1.38M, compared to an average daily volume of 1.22M.

The stock's 52-week range extends from a low of $14.45 to a high of $28.35.

The stock's 52-week range extends from a low of $14.45 to a high of $28.35.

ACAD News

Simply Wall St 17h
A Look At ACADIA Pharmaceuticals Valuation As Recent Returns Send Mixed Signals

Advertisement Recent share performance and business snapshot Without a specific headline event setting the tone, ACADIA Pharmaceuticals (ACAD) is drawing atte...

A Look At ACADIA Pharmaceuticals Valuation As Recent Returns Send Mixed Signals
TipRanks 1d
Acadia Announces Planned Retirement of Head of R&D

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

76%

of 21 ratings
Buy
76.2%
Hold
19%
Sell
4.8%

People also own

Based on the portfolios of people who own ACAD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.